Cover Image


View/Hide Left Panel

47. Merchant JA, Ortmeyer C. Mortality of employees of two cotton mills in North Carolina. Chest (1981) 79(suppl 4):6S-11S.

48. Jones RN, Diem JE, Glindmeyer H, et al. Mill effect and dose-response relationships in byssinosis. Brit J Indust Med (1979) 36:305-313.

49. Kamat SR, Kamat GR, Salpeker H, et al. Distinguishing byssinosis from chronic obstructive pulmonary disease. Am Rev Respir Dis (1981) 124:31-40.

50. Schacter EN, Maunder LR, Beck GJ. The pattern of lung function abnormalities in cotton textile workers. Am Rev Respir Dis (1984) 129:523-527.

51. Glindmeyer HW, Lefante JJ, Jones RN, et al. Exposure-related declines in the lung function of cotton textile workers: relationship to current workplace standards. Am Rev Respir Dis (1991) 144:675-683.

52. Berry G, Molyneux MKB, Tombleson JBL. Relationships between dust levels and byssinosis and bronchitis in Lancashire cotton mills. Brit J Indust Med (1974) 31:18-27.

53. Christiani D. Unpublished data.

54. Martin CVF, Higgins JE. Byssinosis and other respiratory ailments. (1976) J Occup Med 16:455-462.

55. Musk AW, Peters JM, Wegman DH. Isocyanates and respiratory disease: current status. Am J Indust Med (1988) 13:331-349.

56. Fuchs S, Valade P. Etudes cliniques et experimentales sur quelques cas d'intoxication par le desmodur T (diisocyanate de toluylene) 1-2-4 et 1-2-6. Arch Mal Prof (1951) 12:191-196.

57. Moller DR, McKay RT, Bernstein II, Brooks SM. Persistent airways disease caused by toluene diisocyanate. Am Rev Respir Dis (1986) 134:175-176.

58. Adams WGF. Lung function of men engaged on the manufacture of toluene diisocyanate (TDI). Proc Roy Soc Med (1975) 63:378-379.

59. Porter CV, Higgins RI, Scheel LD. A retrospective study of clinical, physiologic and immunologic changes in workers exposed to toluene diisocyanate. Am Ind Hyg Assoc J (1975) 36:159-168.

60. Smith AB, Brooks SM, Blanchard J, Bernstein IL, Gallagher J. Absence of airway hyperreactivity to methacholine in a worker sensitized to toluene diisocyanate (TDI). J Occup Med (1980) 22:327-331.

61. Mapp CE, Dal Vecchio L, Boschetto P, De Marzo N, Fabbri LM. Toluene diisocyanate-induced asthma without airway hyperresponsiveness. Eur J Respir Dis (1986) 68:89-95.

62. Paggiaro PL, Baci E, Dente F, Talini D, Giutini C. Prognosis of occupational asthma induced by isocyanates. Bull Eur Physiopathol Respir (1988) 23:565-569.

63. Lozewicz S, Assoufi BK, Hawkins R, Newman-Taylor AJ. Outcome of asthma induced by isocyanates. Brit J Dis Chest (1987) 81:14-22.

64. Mapp CE, Corona PC, DeMarzo N, Fabbri L. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI). Am Rev Respir Dis (1988) 137:1326-1329.

65. Axford AT, McKerrow CB, Jones AP, Le Quesne PM. Accidental exposure to isocyanate fumes in a group of firemen. Brit J Indust Med (1976) 33:65-71.

66. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Chest (1985) 88:376-384.

67. Peters JM, Murphy RLH, Pagnotto LD, Van Ganse WF. Acute respiratory effects in workers exposed to low levels of toluene diisocyanate (TDI). Arch Environ Health (1968) 16:642-647.

68. Peters JM. Cumulative pulmonary effects in workers exposed to tolylene diisocyanate. Proc Roy Soc Med (1970) 63:14-17.

69. Peters JM, Wegman DH. Epidemiology of toluene diisocyanate (TDI) induced respiratory disease. Environ Health Perspect (1975) 11:97-100.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement